Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1643-8 · Cited by 2,056

Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015

Wang, Z., Chen, Z., Zhang, L., Wang, X., Hao, G., Zhang, Z., Shao, L., Tian, Y., Dong, Y., Zheng, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032380 · Cited by 1,698

Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2951-z · Cited by 715

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

Yang, P., Gu, H., Zhao, Z., Wang, W., Cao, B., Lai, C., Yang, X., Zhang, L., Duan, Y., Zhang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07027 · Cited by 283

ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway

Ye, R., & Liu, Z. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104350 · Cited by 205

Beta Blocker and Angiotensin-Converting Enzyme Inhibitor Therapy Is Associated with Decreased Th1/Th2 Cytokine Ratios and Inflammatory Cytokine Production in Patients with Chronic Heart Failure

Gage, J. R., Fonarow, G. C., Hamilton, M. A., Widawski, M., Martı́nez-Maza, O., & Vredevoe, D. L. (2004) · NeuroImmunoModulation · doi:10.1159/000076766 · Cited by 81

Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension

Moon, J.-Y. (2013) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2013.11.2.41 · Cited by 81

Stalling the Enemy: Targeting Nsp13 for Next-Generation SARS-CoV-2 Antivirals

Castro, J. M., Slack, R. L., Ong, Y. T., Zhang, H., Gifford, L. B., Courouble, V. V., Aiken, R. M., Shankar, V., O’Leary, T. R., Griffin, P. R., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062587 · Cited by 1

Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders

Shekhar, S., Copacino, C. E., Barrera, F. J., Hall, J. E., & Hannah‐Shmouni, F. (2020) · Annals of the National Academy of Medical Sciences (India) · doi:10.1055/s-0040-1713346 · Cited by 2

Médicaments utilisés durant la COVID-19

Ng, T. S. B., Leblanc, K., Yeung, D. F., & Tsang, T. S. M. (2021) · Canadian Family Physician · doi:10.46747/cfp.6703e69 · Cited by 1

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system

Кanorskiy, S. G. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x2021-4-59-67 · Cited by 1

Covid-19 Pandemic and Possible Links with Mthfr Mutations, Homocysteinemia, and Metabolic Disturbances: Short Review

(2020) · Journal of Diabetes and Endocrinology Research · doi:10.47485/2693-2458/1018 · Cited by 1

Evolución del paciente diagnosticado de sindrome respiratorio agudo severo por coronavirus tipo 2 en función de la comorbilidad de la población adscrita al Centro de Salud Zona VI de Albacete

Cantero-Quintero, S., Sáez-Martínez, M., & Castellanos-Garrido, A. B. (2022) · Enfermería Clínica · doi:10.1016/j.enfcli.2022.01.005 · Cited by 1

The effect of renin-angiotensin-aldosterone system blockers on the course of COVID-19 in patients with arterial hypertension

Свеклина, Т. С., Tyuryupov, M. S., Medvedeva, V. A., Борисович, Ш. С., Kuchmin, A. N., & Kozlov, V. A. (2022) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2021-27-6-653-661 · Cited by 1

Patological changes in cardiovascular system among the patients with post-COVID-19 syndrome

Akimochkin, G. S., Volgograd, R. F., Matokhin, S. E., Skvortsov, V. V., Skvortsova, E. M., & Saraev, S. S. (2023) · Therapist’s Bulletin · doi:10.31550/2712-8601-vt-2023-5-6-2 · Cited by 1

COVID-19 Therapeutics Why Not Angiotensin Receptor Blockers (ARBs)?

S, H. T. (2023) · Journal of the Association of Physicians of India · doi:10.59556/japi.71.0393 · Cited by 1

Hospital Mortality and Morbidity in Diabetic Patients with COVID-19: A Retrospective Analysis from the UAE

Mohamed, Y. S., Mukhtar, M., Elmalti, A., Kheirallah, K. A., Panigrahi, D., Abu-rish, E. Y., Bani, I. A., Nasor, E. M., Ahmed, W., & Alzoubi, A. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21060697 · Cited by 1

Systematic Review on Association of Various Disease with Covid-19

Prakash, J., & Lodha, S. (2024) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.3.3.16 · Cited by 1

SARS-CoV-2 und das Renin-Angiotensin-System: was wir wissen

Armelle, T., Eriksson, U., & Krasniqi, N. (2020) · Cardiovascular Medicine · doi:10.4414/cvm.2020.02116 · Cited by 1

Hypertension and COVID-19: A public health perspective

Singh, A., Shah, A. N., & Narain, J. (2020) · International Journal of Noncommunicable Diseases · doi:10.4103/jncd.jncd_34_20 · Cited by 1

Pharmacological approaches to the treatment of COVID-19 patients

Sowers, L. C., Blanton, L. S., Weaver, S. C., Urban, R. J., & Mouton, C. P. (2020) · Journal of Translational Science · doi:10.15761/jts.1000394 · Cited by 1

Treatment of Multi-Drug Resistant Gram-Negative Bacterial Pathogenic Infections

Akram, W. M., Menezes, G. A., Abbas, N., Ahmad, W., & Ahmed, A. M. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.3.02 · Cited by 1

Practical considerations for cardiovascular care during COVID-19 pandemic

Bhaskar, D. K., Chaudhari, V. M., & Oak, M. A. (2021) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20212306 · Cited by 1

Relationship between the ABO blood group and mortality among the COVID-19 patients

Doğanay, F., & Ak, R. (2021) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.915047 · Cited by 1

Prevalence of comorbidities and its impacts in Hospitalized patients with COVID-19

Khaksar, M. A., Yousefabadi, E. Z., Zadeh, R. T., Rashidi, H., Maniati, M., & Bakhtiari, N. (2021) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v7i5.1081 · Cited by 1

COVID-19 e Doença Cardiovascular: O Impacto da Pandemia

Zanatta, J. M. D. M., & Falcão, L. M. (2021) · Medicina Interna · doi:10.24950/r/163/20/1/2021 · Cited by 1

The use of renin-angiotensin system blockers in patients with COVID-19

Rodionov, A. V. (2021) · Consilium Medicum · doi:10.26442/20751753.2021.10.201139 · Cited by 1

SARS-CoV-2 and Microbiota

Russo, E., Curini, L., Fabbrizzi, A., & Amedei, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-8957-4_14 · Cited by 1

Cardiovascular System and SARS-CoV-2: Etiology, Physiopathology and Clinical Presentation: A Systematic Review

Júnior, J. G., Cândido, E. L., de Oliveira, G. F., & Neto, M. L. R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97076 · Cited by 1

Possible Role of Vitamin D3 in the Prevention of COVID-19 Infection and Mortality

Ataee, R. (2022) · Open Access Journal of Endocrinology · doi:10.23880/oaje-16000163 · Cited by 1

THE EVOLUTION AND TREATMENT OPTIONS OF PATIENTS WITH COVID-19 AND NEUROLOGICAL MANIFESTATIONS – A NARRATIVE REVIEW

Odajiu, I. (2022) · FARMACIA · doi:10.31925/farmacia.2022.6.2 · Cited by 1

The Association Between Some Endocrine Conditions and COVID-19: A Review

Smail, H. O. (2022) · Biology Medicine & Natural Product Chemistry · doi:10.14421/biomedich.2023.121.45-53 · Cited by 1

Renin-Angiotensin-Aldosterone-System Blocking Drugs in Patients with SARS-CoV-2 - Systematic Review and Meta-AnalysisPreprint

Chu, C., Zeng, S., Hasan, A., Hocher, C., Kraemer, B., & Hocher, B. (2020) · doi:10.22541/au.159170759.99707886 · Cited by 1

Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Use and COVID-19: Time to Change Practice or Keep Gathering Data?

de Feria, A., & Ortega–Legaspi, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa819 · Cited by 1

Pre-exposure to anti-TNFα decreases COVID-19 symptoms: a multicentre retrospective cohort studyPreprint

Soldevila‐Domenech, N., Tío, L., Llorente‐Onaindia, J., Martín‐García, E., Nebot, P., de la Torre, R., Gurt, A., Maldonado, R. J., & Monfort, J. (2020) · doi:10.22541/au.159103645.57164898 · Cited by 1

Association of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: A systematic review and meta-analysisPreprint

Biswas, M., & Kali, M. S. K. (2020) · doi:10.21203/rs.3.rs-39141/v1 · Cited by 1

STUDY OF BLOOD GROUP ANALYSIS AND ITS CORRELATION WITH LYMPHOPENIA IN COVID-19 INFECTED CASES – OUR EXPERIENCE IN TERITARY CARE HOSPITALPreprint

Ravuri, S., Saritha, C., Kalangi, H., Jeshtadi, A., Kumar, K. N., Krishna, N. V., Bacchu, S., & Sudhakar, K. (2021) · medRxiv · doi:10.1101/2021.07.12.21258824 · Cited by 1

A PHARMACOLOGICAL FRAMEWORK FOR INTEGRATING TREATING THE HOST, REPUPOSING AND THE DAMAGE RESPONSE FRAMEWORK IN COVID19 DISEASEPreprint

Head, R. J., & Martin, J. H. (2020) · doi:10.22541/au.159406963.36790138 · Cited by 1

FUTURE PROGNOSIS FOR CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH SARS-COV-2: A PHARMACOLOGICAL AND MOLECULAR PERSPECTIVEPreprint

R, A. V. P., Jha, A. P., P, R. S., Sharma, A., Sharma, K., & Khandelwal, A. (2023) · doi:10.22541/au.170046905.54322057/v1 · Cited by 1

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications

Lima, N. D. A., Lima, P. Y. P., de Castro, R. L., Sieloff, E. M., & Sampaio, S. M. V. (2020) · Journal of Cardiac Arrhythmias · doi:10.24207/jca.v33i1.3367

Protective role of ACE inhibitors and ARBs in hypertensive patients suffering from COVID-19Preprint

Talukdar, A., Sarkar, D., Roychowdhury, S., & Ganguly, D. (2020) · doi:10.22541/au.158955396.63298622

(Treatment with ACE inhibitors and AT1-blockers during the COVID-19 pandemic)

Veselý, J. (2020) · Cor et Vasa · doi:10.33678/cor.2020.047

Cardiovascular disease in the context of the COVID-19 pandemic

Mendis, S. (2020) · International Journal of Noncommunicable Diseases · doi:10.4103/jncd.jncd_31_20

First-generation Corona Virus Disease 2019 (COVID-19) patients with a Wuhan-traveling history are prone to more severe diseasesPreprint

Zhang, P., Chen, J., Xiao, G., Chen, P., Liu, S., Li, X., Li, Y., Zhang, S., Bi, J., Feng, S., et al. (2020) · doi:10.22541/au.159188481.10875549

Pharmacotherapy of COVID-19: confine to existential drugs or search for new ones?Preprint

Hatip‐Al‐Khatib, I., & Hatip, F. F. B. (2020) · doi:10.14293/s2199-1006.1.sor-.pp0j7ng.v1

El tratamiento con bloqueadores del sistema Renina-Angiotensina-Aldosterona no debe suspenderse tras la infección por SARS-CoV-2

Bryce, A., Portmann-Baracco, A., & Bryce‐Alberti, M. (2020) · Archivos Peruanos de Cardiología y Cirugía Cardiovascular · doi:10.47487/apcyccv.v1i2.62

Knowing When and How to Fight: COVID-19 Between Viral Clearance and Immune Tolerance

Utomo, A. R. H. (2020) · Journal of Biomedicine and Translational Research · doi:10.14710/jbtr.v6i2.8472

A Rapid Strategy for Repurposing Drugs for COVID-19

Khoubnasabjafari, M., Amanlou, M., Dehpour, A. R., & Jouyban, A. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2020.76

THE ANALYSIS OF THE FEATURES OF DALARGIN EFFECT ON THE RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH COVID-19

Martynov, Y., & Kukovska, I. (2020) · ΛΌГOΣ МИСТЕЦТВО НАУКОВОЇ ДУМКИ · doi:10.36074/2663-4139.14.01

The COVID-19 Code – Cracked – WHO can Save The World (?)!

Kuppuswamy, V., Nagarajan, D., Balasubramaniam, S., Velmurugan, R., Kottililkutty, S., & Tarra, D. (2020) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt20aug276

Infekcja COVID-19 u pacjentów obciążonych nadciśnieniem tętniczym

Mazur-Mucha, M., Szyndler, A., & Chrostowska, M. (2020) · Choroby Serca i Naczyń · doi:10.5603/chsin.2020.0011

Cessation of Renin-Angiotensin System Antagonists During the SARS-CoV-2 Pandemic – Do We Have the Evidence?

Blîndu, E., Gerculy, R., Opincariu, D., Cernica, D., & Benedek, I. (2020) · Journal of Interdisciplinary Medicine · doi:10.2478/jim-2020-0022

Brave new world an update on COVID-19 pandemic – A review

Gadó, K., Domján, G., & Nagy, Z. Z. (2020) · Developments in Health Sciences · doi:10.1556/2066.2020.00009

The Potential Role of ACEi and ARBs in COVID-19; A Perspective

Hassan, A. H. (2020) · Proceedings of Shaikh Zayed Medical Complex Lahore · doi:10.47489/p000s342z7441-4mc

Efectos de Bloqueadores del Receptor de Angiotensina II e inhibidores de la Enzima Convertidora de Angiotensina en COVID-19: Una revisión narrativa de la literatura

Loaiza, J. D. M., Infante-Fernández, H. S., Mahecha, B. S. P., Herrera-Cardona, J. E., & Jiménez, D. R. S. (2020) · Revista Investigación en Salud Universidad de Boyacá · doi:10.24267/23897325.473

CME: L’hypertension artérielle et la pandémie COVID-19: Ce qu’il faut retenir en pratique médicale

Wuerzner, G., & Waeber, B. (2021) · Praxis · doi:10.1024/1661-8157/a003639

Taking Renin-Angiotensin Drugs in Patients with COVID-19: Start, Continue, or Stop; a Literature Review

Sharifkazemi, M. (2021) · مجله دانشگاه علوم پزشکی اردبیل · doi:10.52547/jarums.20.2.176

CME: Hypertonie und die COVID-19-Pandemie: Was in der medizinischen Praxis zu beachten ist

Wuerzner, G., & Waeber, B. (2021) · Praxis · doi:10.1024/1661-8157/a003635

RAAS-Blockade in COVID-19: The Ace of Spades?

Agarwal, K. A., Kyriazis, P. P., & Lecker, S. H. (2021) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_322_20

Pathophysiology of COVID-19 and its potential therapeutics

Khan, S. A., & Siddiqui, N. I. (2021) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20210193

Clinical effects of angiotensin-converting-enzyme inhibitors on lung computed tomography findings in patients with COVID-19 pneumonia: Is it useful?Preprint

Yavuz, B. G., & Çolak, Ş. (2021) · doi:10.22541/au.161354289.95968971/v1

O papel dos inibidores da enzima conversora de angiotensina e dos antagonistas dos receptores de angiotensina em pacientes com Covid-19: uma revisão narrativa

Asturian, K. (2021) · Revista de Ciências Médicas · doi:10.24220/2318-0897v30e2021a5035

Effects of Different Anti-hypertensive Drugs on Hospitalized Patients With COVID-19 and Hypertension in ChinaPreprint

Shi, X., Cao, M., Liu, S., Chen, P., Hu, F., Su, Z., Jiang, S., Wang, F., Zhang, Y., Gao, H., et al. (2020) · doi:10.21203/rs.3.rs-95019/v1

COVID-19 Treatment Options and Vaccination in India: A Perspect

Grace, N. S., SOWMINI, K., Veena, B., & Sruthi, V. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.sp190

Renin-angiotensin-aldosterone system inhibitors and covid-19 complications

de Mattos, A. F., Barsotti, N. S., & Almeida, R. R. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n2-143

The effect of renin-angiotensin-aldosterone blockers on SARS-CoV-2 infection in adults: a systematic review of studies and meta-analyzes

Васильевна, Л. М. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-4-26-33

COVID-19, Hypertension, and Diabetes – Hunt for the Link!

Saha, K., & Mukherjee, S. (2021) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_40_20

Antihypertensives and COVID-19: Literature review

da Silva, T. C. L., Villarim, P. V. D. O., de Goés, A. B. M., Marinho, V. R. D., Araújo, N. M., Silva, A. L. C. E., do Rêgo, A. C. M., & Araújo-Filho, I. (2021) · Research Society and Development · doi:10.33448/rsd-v10i6.15977

Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patients

Başlılar, Ş., & Şaylan, B. (2021) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2021.268

Review: COVID-19 Outbreak and Diabetic Patient’s Treatments Close Relationship

Khan, H. H., Guo, H., Achakzai, S. K., Zhao, Y., Ullah, H., Hussain, S., Ahmad, S., Nadeem, Z., Ahmad, U., Alam, K., et al. (2021) · American Journal of Nursing Science · doi:10.11648/j.ajns.20211006.11

Clinical Outcome of Renin-Angiotensin-Aldosterone System Blockers in Treatment of Hypertensive Patients with COVID-19: A Systematic Review and Meta-AnalysisPreprint

Laurentius, A., Mendel, B., & Prakoso, R. (2020) · Research Square · doi:10.21203/rs.3.rs-69847/v1

The effect of ARBs and ACEIs on SARS-CoV-2: Exploring the controversy

Badawy, S., & Miller, B. (2022) · STEM Fellowship Journal · doi:10.17975/sfj-2022-003

Clinical characteristics, laboratory profile and imaging results in COVID-19 cases

Nematshahi, M., Neamatshahi, M., Attarian, F., Soroosh, D., & Rahimi, F. (2022) · Journal of Clinical Images and Medical Case Reports · doi:10.52768/2766-7820/1612

Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?

Vehbi, S., Yıldız, A. B., & Kanbay, M. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac122

COVID-19 Screening in Rheumatologic Diseases Cases; Special Look at Chloroquine Derivate Use

Shadmanfar, S., Alishiri, G. H., Bayat, N., Izadi, M., Salimzadeh, A., Rostamian, A., Abolghasemi, S., Ardebili, M. H. A., Moqaddam, Z. R., Hasani, M., et al. (2021) · Hospital Practices and Research · doi:10.34172/hpr.2021.27

RAAS inhibitors for hypertensive patients during Covid-19 infection – a metanalysis

Doull, F., Thomas, G., & Gemmell, E. (2021) · Journal of Student Research · doi:10.47611/jsr.v10i4.1401

La práctica de la cardiología ante la pandemia por COVID-19. Recomendaciones de la comunidad cardiológica mexicana

Buendía-Hernández, A., Alcocer-Gamba, M. A., & Sierra-Fernández, C. (2020) · Cardiovascular and Metabolic Science · doi:10.35366/93942

First-Generation Corona Virus Disease 2019 (COVID-19) Patients with a Wuhan-Traveling History are Prone to More Severe DiseasesPreprint

Zhang, P., Chen, J., Xiao, G., Chen, P., Liu, S., Li, X., Li, Y., Zhang, S., Bi, J., Feng, S., et al. (2020) · doi:10.21203/rs.3.rs-38892/v1

Impact of COVID-19 on cardiovascular diseases: considerations for patients and healthcare systemsPreprint

Jiang, Z. (2020) · doi:10.31219/osf.io/d7kyw

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomesPreprint

Bezabih, Y. M., Bezabih, A., Alamneh, E. A., Peterson, G. M., & Bezabhe, W. M. M. (2020) · Research Square · doi:10.21203/rs.3.rs-85373/v1

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals: Retrospective Cohort StudyPreprint

Alrashed, A. A., Khan, T. M., Alhusseini, N. K., Asdaq, S. M. B., Enani, M. A., Alosaimi, B., Alkhani, N., Mohzari, Y. A., Alghalbi, M., Alfahad, W. A., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-113824/v1

The human-COVID-19 Tango: Connecting the DotsPreprint

Hamdi, H., & Abdaldayem, E. (2020) · Preprints.org · doi:10.20944/preprints202004.0160.v2

COVID-19 y el sistema renina, angiotensina, aldosterona. Una relación compleja

Díaz-Barreiro, L. A., Cossío-Aranda, J. E., Verdejo-París, J., Ríos, M. O.-D. L., Galván‐Oseguera, H., Álvarez‐López, H., & Alcocer-Gamba, M. A. (2020) · Cardiovascular and Metabolic Science · doi:10.35366/93945

Pre-exposure to anti-TNFα decreases COVID-19 symptoms: a multicentre retrospective cohort studyPreprint

Soldevila‐Domenech, N., Tío, L., Llorente‐Onaindia, J., Martín‐García, E., Nebot, P., de la Torre, R., Gurt, A., Maldonado, R. J., & Monfort, J. (2020) · doi:10.22541/au.159164105.50210988

The Potential Role of ACEi and ARBs in COVID-19; A PerpsectivePreprint

Hassan, A. H. (2020) · doi:10.31219/osf.io/4gfqu

Risk factors for severity and mortality in adults testing positive for COVID-19 in the VI Health Area of Albacete

Cantero-Quintero, S., Sáez-Martínez, M., & Castellanos-Garrido, A. B. (2022) · Enfermería Clínica (English Edition) · doi:10.1016/j.enfcle.2022.01.003

Avaliação da qualidade de vida dos enfermeiros diagnosticados com a COVID-19: retratos da pandemia no Brasil (2020)

Brito, S. D. A. (2022) · doi:10.11606/d.22.2022.tde-18082022-121212

Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies

Shahali, A., Akbari, V., Soltani, R., Badri, S., & Ardeshir, R. A. (2022) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.39.4.56

The effect of ACE inhibitors on inflammation and clinical end-points in COVID-19 patients

(2022) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21243

Interactions between the renin–angiotensin–aldosterone system and COVID-19

Habeichi, N. J., Amin, G., Massoud, G. P., Diab, R., Mericskay, M., Booz, G. W., & Zouein, F. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99618-1.00006-4 · Cited by 1

Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study

Iraj, B., Moravejolahkami, A. R., Sami, R., Riahinezhad, M., Tasdighi, Z., Toghyani, A., Hosseini, N., Niri, F. D., & Askari, G. (2023) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_373_22

Conhecimento fast track e orientação terapêutica: explorando as evidências relativas ao uso de inibidores do SRAA em pacientes hipertensos com COVID-19

Filho, A. C. E. S., da Silva, G. O. S., Filho, L. F. F. G., & Vianna, P. V. C. (2023) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.rmrp.2023.196221

ALTERAÇÕES HEMATOLÓGICAS NA INFECÇÃO POR SARS-COV-2 NO MUNICIPIO DE CAÇADOR/SC: ESTUDO RETROSPECTIVO

de Moura, T. R., Bellaver, E. H., & Zancanaro, V. (2023) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v9i4.9321

Diabetes and COVID

Zordok, M., & Johnstone, M. T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_36

Clinical presentation, ICU management and outcome in severe COVID-19 disease – A prospective observational study

Prakash, S. (2023) · Annals of Antivirals and Antiretrovirals · doi:10.17352/aaa.000017

A Study of Prognosis and Outcome of COVID-19-Infected Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers

Bharath, M. S., Ravitej, S., Balgi, V., Urs, M. C. R. R., & Apoorva, C. (2023) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_91_22

Development of plant-produced subunit vaccine and therapeutic protein for COVID-19

Siriwattananon, K. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.306

COVID-19 and arterial hypertension: points of contact and outcomes of the pathological process

Dzhusoeva, E. G., & Моисеева, М. В. (2023) · Scientific Bulletin of the Omsk State Medical University · doi:10.61634/2782-3024-2023-9-41-48

ANGIOTENSIN II AS A BIOMARKER OF COVID-19 SEVERITY AND PROGNOSIS IN CHILDREN

(2023) · Al-Azhar Journal of Pediatrics · doi:10.21608/azjp.2023.325929

COVID-19 HAS BROAD EFFICACY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH HEART FAILURE

Ansari, A., Yusuf, K. A., Alaazmi, N. H., & Awadh, D. M. (2023) · Journal Of Healthcare In Developing Countries · doi:10.26480/jhcdc.01.2023.22.27

The Potential Role of Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers in Reducing Pneumonia Severity in Older Adults

Thomas, H., Yoshimatsu, Y., Thompson, T., & Smithard, D. G. (2024) · Cureus · doi:10.7759/cureus.57463

Clinical characteristics and mortality in mechanically ventilated COVID-19 patients: prospective cohort study

García, A. F., Vargas-Ordóñez, M. P., Gómez-Martínez, J. D., Gempeler, A., & Chica, J. (2024) · Colombian Journal of Anesthesiology · doi:10.5554/22562087.e1107

Controlling blood pressure and progression of hypertension-dependent cardiovascular continuum by amlodipine and perindopril A single pill fixed‑dose combination: focus on endothelial dysfunction and metabolic risks

Свеклина, Т. С., Kuchmin, A. N., Konyaev, V. V., Дмитриевна, О. П., & Rechkalova, A. I. (2024) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2024-2435

The effect of pre-hospital use of RAS inhibitors on COVID-19 mortality

Ibrahim, R. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241270417

Microbiome and the COVID-19 pandemic

Patel, P. R., & Bhattacharjee, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-90144-4.00008-2

Outcome of COVID-19 infection in patients on antihypertensives: A cross-sectional study

Varatharajan, S., Bohra, G. K., Bhatia, P. K., Khichar, S., Meena, M., Palanisamy, N., Archana Gaur, T., & Garg, M. K. (2024) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v13.i3.96882

Role of ACE Inhibitors and Angiotensin Receptor Blockers in Covid19 Patients

Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7380-0_9 · Cited by 1

Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.

Dworakowska, D., & Grossman, A. B. (2020) · PubMed · doi:10.26402/jpp.2020.2.01 · Cited by 12

Use of inhibitors of the renin‐angiotensin system in hypertensive patients and COVID‐19 severity: A systematic review and meta‐analysis

Barochiner, J., & Martínez, R. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13246 · Cited by 56

Comparison of Renin–Angiotensin–Aldosterone System Inhibitors with Other Antihypertensives in Association with Coronavirus Disease-19 Clinical Outcomes: Systematic Review and Meta-AnalysisPreprint

Bezabih, Y. M., Bezabih, A., Alamneh, E. A., Peterson, G. M., & Bezabhe, W. M. M. (2020) · Preprints.org · doi:10.20944/preprints202005.0392.v1

Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysisPreprint

Beressa, T. B., Sahilu, T., & Deyno, S. (2020) · medRxiv · doi:10.1101/2020.09.03.20187393 · Cited by 4

[Differences among renin-angiotensin system inhibitor drugs in prognosis of hypertense patients with COVID-19].

Caamaño, M. N., Rio, J. M., Nieto-Sandoval-Martín-de-la-Sierra, P., Águila‐Gordo, D., Mateo-Gómez, C., Rodríguez-Martínez, M., Salas-Bravo, D., & Piqueras‐Flores, J. (2022) · PubMed Central · doi:10.24875/acm.21000185